ArticleOncotarget2018

The down-regulation of the CYP2C19 gene is associated with aggressive tumor potential and the poorer recurrence-free survival of hepatocellular carcinoma.

Ryo Ashida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.